Medical ProductsCompany
Aptevo Therapeutics - Hyperimmune Commercial Products Ownership
Who owns Aptevo Therapeutics - Hyperimmune Commercial Products?
Aptevo Therapeutics - Hyperimmune Commercial Products is owned by Saol Therapeutics. It was acquired on August 31, 2017.
Aptevo Therapeutics - Hyperimmune Commercial Products Business Overview
Where is Aptevo Therapeutics - Hyperimmune Commercial Products headquartered?
Aptevo Therapeutics - Hyperimmune Commercial Products is headquartered in Seattle, Washington.
What sector is Aptevo Therapeutics - Hyperimmune Commercial Products in?
Aptevo Therapeutics - Hyperimmune Commercial Products is a medical products company.
Medical Products M&A Summary in 2017
Out of 60 sectors in the Mergr database, medical products ranked 13 in number of deals in 2017. The largest medical products acquisition in 2017 was C. R. Bard - which was acquired by Becton Dickinson for $24.0B.
Join Mergr to view all 209 acquisitions of medical products companies in 2017, including 27 acquisitions by private equity firms, and 182 by strategics.